Peptides as Drugs: Discovery and Development

Peptides as Drugs: Discovery and Development

Volumn , Issue , 2009, Pages 1-8

  Groner, Bernd ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

Disruption of protein interactions; Druggability; Innovative drug targets; Peptides as competitive interaction inhibitors; Protein interaction domains

Indexed keywords

EID: 84857790776     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626830.ch1     Document Type: Chapter

References (28)

1. Kaushik , D.K. and Sehgal , D. ( 2008 ) Developing antibacterial vaccines in genomics and proteomics era . Scand. J. Immunol. , 67 ( 6 ), 544-52 .
2. Chen , Y. , Zhu , J. et al . ( 2008 ) Variations in DNA elucidate molecular networks that cause disease . Nature , 452 ( 7186 ), 429-35 .
3. Jones , S. , Zhang , X. , Parsons , D.W. et al . ( 2008 ) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses . Science , 321 ( 5897 ), 1801-6 .
4. Parsons , D.W. , Jones , S. , Zhang , X. et al . ( 2008 ) An integrated genomic analysis of human glioblastoma multiforme . Science , 321 ( 5897 ), 1807-12 .
5. Greenman , C. , Stephens , P. et al . ( 2007 ) Patterns of somatic mutation in human cancer genomes . Nature , 446 ( 7132 ), 153-8 .
6. Vogelstein , B. and Kinzler , K.W. ( 2004 ) Cancer genes and the pathways they control . Nat. Med. , 10 ( 8 ), 789-99 .
7. Seet , B.T. , Dikic , I. et al . ( 2006 ) Reading protein modifications with interaction domains . Nat. Rev. Mol. Cell. Biol. , 7 ( 7 ), 473-83 .
8. Sharma , S.V. and Settleman , J. ( 2007 ) Oncogene addiction: setting the stage for molecularly targeted cancer therapy . Genes Dev. , 21 ( 24 ), 3214-31 .
9. Collins , I. and Workman , P. ( 2006 ) New approaches to molecular cancer therapeutics . N at. Chem. Biol. , 2 ( 12 ), 689-700 .
10. Sharma , S.V. , Bell , D.W. et al . ( 2007 ) Epidermal growth factor receptor mutations in lung cancer . Nat. Rev. Cancer , 7 ( 3 ), 169-81 .
11. Hopkins , A.L. and Groom , C.R. ( 2002 ) The druggable genome . Nat. Rev. Drug Discov. , 1 ( 9 ), 727-30 .
12. Betz , U.A. , Farquhar , R. et al . (2005) Genomics: success or failure to deliver drug targets? Curr. Opin. Chem. Biol. , 9 ( 4 ), 387-91 .
13. Keller , T.H. , Pichota , A. et al . ( 2006 ) A practical view of ' druggability ' . Curr. Opin. Chem. Biol. , 10 ( 4 ), 357-61 .
14. Imming , P. , Sinning , C. et al . ( 2006 ) Drugs, their targets and the nature and number of drug targets . Nat. Rev. Drug Discov. , 5 ( 10 ), 821-34 .
15. Russ , A.P. and Lampel , S. ( 2005 ) The druggable genome: an update . Drug. Discov. Today , 10 ( 23-24 ), 1607-10 .
16. Pawson , T. ( 2004 ) specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems . Cell , 116 ( 2 ), 191-203 .
17. Li , S. , Armstrong , C.M. et al . ( 2004 ) A map of the interactome network of the metazoan C. elegans . Science , 303 ( 5657 ), 540-3 .
18. Chene , P. ( 2006 ) Drugs targeting protein-protein interactions . ChemMedChem , 1 ( 4 ), 400-11 .
19. Pal , A. , Chakrabarti , P. et al . ( 2007 ) Peptide segments in protein-protein interfaces . J . Biosci. , 32 ( 1 ), 101-11 .
20. Wodak , S.J. and Janin , J. ( 2002 ) Structural basis of macromolecular recognition . Adv. Protein Chem. , 61 , 9-73 .
21. Berg , T. ( 2008 ) Inhibition of transcription factors with small organic molecules . Curr. Opin. Chem. Biol. , 12 ( 4 ), 464-71 .
22. White , A.W. , Westwell , A.D. et al . ( 2008 ) Protein-protein interactions as targets for small-molecule therapeutics in cancer . Expert. Rev. Mol. Med. , 10 , e 8 .
23. Jones , D.S. , Silverman , A.P. et al . ( 2008 ) Developing therapeutic proteins by engineering ligand-receptor interactions . Trends Biotechnol. , 26 ( 9 ), 498-505 .
24. Lo Conte , L. , Chothia , C. et al . ( 1999 ) The atomic structure of protein-protein recognition sites . J. Mol. Biol. , 285 ( 5 ), 2177-98 .
25. Sillerud , L.O. and Larson , R.S. ( 2005 ) Design and structure of peptide and peptidomimetic antagonists of protein -protein interaction . Curr. Protein Pept. Sci. , 6 ( 2 ), 151-69 .
26. Baines , I.C. and Colas , P. ( 2006 ) Peptide aptamers as guides for small-molecule drug discovery . Drug Discov. Today , 11 ( 7-8 ), 334-41 .
27. Borghouts , C. , Kunz , C. et al . ( 2005 ) Current strategies for the development of peptide-based anti-cancer therapeutics . J. Pept. Sci. ( 11 ), 713-26 .
28. Borghouts , C. , Kunz , C. et al . ( 2008 ) Peptide aptamer libraries . Comb. Chem. High Throughput Screen. , 11 ( 2 ), 135-45 .